Avian Influenza: Are We Ready?

Critical Care Nursing Clinics of North America

Volumn 19, Issue 1, 2007, Pages 107-113

  Krau, Stephen D ^a   Parsons, Lynn C ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MIDDLE TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE TRANSMISSION; EPIDEMIC; ETHICS; HUMAN; INFLUENZA; INFLUENZA VIRUS A H5N1; OCCUPATIONAL DISEASE; PARAMEDICAL PERSONNEL; REVIEW; VIROLOGY;

ALLIED HEALTH PERSONNEL; DISEASE OUTBREAKS; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; OCCUPATIONAL DISEASES;

EID: 33847309099     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2006.10.009     Document Type: Review

References (29)

1. Zoloth L., and Zoloth S. Don't be chicken: bioethics and avian flu. Am J Bioeth 6 1 (2006) 5-8
2. Barnitz L., and Berkwits M. The health care response to pandemic influenza. Ann Intern Med 145 2 (2006) 135-137
3. Anderson E. Avian flu-are you prepared to fight a pandemic?. AAOHN J 54 1 (2006) 8-10
4. Poland G. Vaccines against avian influenza-a race against time. N Engl J Med 354 13 (2006) 1411-1413
5. World Health Organization. Avian influenza. Cummulative number of confirmed human cases of avian influenza A/(H5N1) reported to the WHO. Available at: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2006_08_23/en/index.html. Accessed September 30, 2006.
6. Bartlett J. Planning for avian influenza. Ann Intern Med 145 2 (2006) 141-149
7. Salgado C.D., Farr B.M., Hall K.K., et al. Influenza in the acute hospital setting. Lancet Infect Dis 2 (2002) 145-155 [Erratum, Lancet Infect Dis 2002;2:283]
8. Bridges C.B., Kuehnert M.J., and Hall C.B. Transmission of influenza: implications for control in health care settings. Clin Infect Dis 37 (2003) 1094-1101
9. Beigel J.H., Farrar J., Han A.M., et al. Avian influenza A (H5N1) infections in humans. N Engl J Med 353 (2005) 1374-1385
10. Jin X.W., and Mossad S.B. Avian influenza: an emerging pandemic threat. Cleve Clin J Med 12 72 (2005) 1129-1134
11. Hien T.T., Liem N.T., Dung N.T., et al. Avian influenza A (H5N1) in 10 patients in Viet Nam. N Engl J Med 350 (2004) 1179-1188
12. Ungchosak K., Auewarakul P., Dowell S.F., et al. Probably person to person transmission of avian influenza A (H5N1). N Engl J Med 352 (2005) 333-340
13. Kyoko S., Ebina M., Yamada S., et al. Influenza virus receptors in the human airway. Nature 440 7083 (2006) 435-436
14. Chotpitayasunonduh T., Ungchusak K., Hanshaoworakul W., et al. Human disease from influenzae A (H5N1), Thailand 2004. Emerg Infect Dis 11 (2005) 201-209
15. Chan P.K. Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 34 Suppl 2 (2002) S58-S64
16. de Jong M.D., and Hien T.T. Avian influenza A (H5N1). J Clin Virol 35 1 (2006) 2-13
17. Nicholson K.G., Wood J.M., and Zambon M. Influenza. Lancet 362 (2003) 1733-1745
18. Center for Disease Control and Prevention. Interim recommendations for infection control in health-care facilities caring for patients with known or suspected avian influenxa. Available at: http://www.cdc.gov/flu/avian/professional/infect-control.htm. Accessed October 12, 2006.
19. Wong S.S., and Yuen K. Avian influenza virus infections in humans. Chest 129 1 (2006) 156-168
20. Treanor J.J., Campbell J.D., Zangwill K.M., et al. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 354 13 (2006) 1343-1351
21. Hehme N., Engelmann H.J., and Kuenzel W. Immunogenecity of a monovalent aluminum-adjuvanted influenza whole virus vaccine for pandemic use. Virus Res 103 (2004) 163-171
22. Belshe R.B., Newman F.K., Cannon J., et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 351 (2004) 2286-2294
23. Kenney R.T., Frech S.A., Muenz L.R., et al. Dose sparring with intradermal injection of influenza vaccine. N Engl J Med 351 (2004) 2295-2301
24. Stephenson I., Nicholson K.G., Colegate A., et al. Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore 97 vaccine in a primed human population. Vaccine 21 (2003) 1687-1693
25. Monto A.S. Vaccines and antiviral drugs in pandemic preparedness. Emerg Infect Dis 12 1 (2006) 55-60
26. Ferguson N.M., Cummings D.A., Fraser C., et al. Strategies for mitigating an influenza pandemic. Nature 442 7107 (2006) 448-452
27. Koh D., Lim M.K., Chia S.E., et al. Risk perceptions and impact of severe acute respiratory syndrome (SARS) on work and personal lives of health care workers in Singapore: what can we learn?. Med Care 43 7 (2005) 676-682
28. Bournes D.A., and Ferguson-Pare' M. Persevering through a difficult time during the SARS outbreak in Toronto. Nurs Sci Q 18 4 (2005) 324-333
29. Fauci A.S. Pandemic influenza threat and preparedness. Emerg Infect Dis 12 1 (2006) 73-77